randomized double-blind placebo-controlled cross-over trial side effects medroxyprogesterone acetate hormone replacement therapy Cyclic progestin therapy adjunct estrogen replacement therapy risk endometrial carcinoma Acceptance approach detailed evaluation possible adverse side effects progestins patient noncompliance nonmenstrual physical psychological side effects oral medroxyprogesterone acetate conjunction transdermal estrogen groups women previous hysterectomy oophorectomy Twenty-four women severe premenstrual syndrome PMS surgery women history adverse premenstrual changes transdermal estrogen micrograms days oral medroxyprogesterone acetate mg identical placebo days randomized double-blind cross-over design Mood physical symptoms daily self-ratings Daily Symptoms Checklist Beck Depression Inventory Premenstrual Tension Self-Rating Scale day study completion patients treatment period Paired comparisons significant differences preference treatment medroxyprogesterone acetate placebo addition medroxyprogesterone acetate mg/day days transdermal estrogen therapy days consistent adverse physical psychological effects women cycle treatment PMS history 